A cost-effectiveness analysis of fluvastatin in patients with diabetes after successful percutaneous coronary intervention

This publication has 32 references indexed in Scilit:

• Drug-Eluting Stents
  Annual Review of Medicine, 2004
• An Economic Evaluation of Fluvastatin used for the Prevention of Cardiac Events Following Successful First Percutaneous Coronary Intervention in the UK
  PharmacoEconomics, 2004
• A single European currency for EQ-5D health states
  The European Journal of Health Economics, 2003
• Current Status of Intravascular Stents as Delivery Devices to Prevent Restenosis
  Vascular and Endovascular Surgery, 2003
• Major benefits from cholesterol-lowering in patients with diabetes
  The Lancet, 2003
• Quality of life and time trade-off utility measures in patients with coronary artery disease
  American Heart Journal, 2003
• MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20 536 high-risk individuals: a randomised placebocontrolled trial
  Published by Elsevier ,2002
• Comparison of Coronary-Artery Bypass Surgery and Stenting for the Treatment of Multivessel Disease
  New England Journal of Medicine, 2001
• The Lescol ® Intervention Prevention Study (LIPS): a double-blind, placebo-controlled, randomized trial of the long-term effects of fluvastatin after successful transcatheter therapy in patients with coronary heart disease
  International Journal of Cardiovascular Interventions, 2001
• EuroQol - a new facility for the measurement of health-related quality of life
  Health Policy, 1990